Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul-Kee Park

Showing results (211-220 of 334) with videos related to

Pageof 34
Sort By:
Plos One|November 19, 2016
Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR ImagingLeonard Sunwoo, Tae Jin Yun, Sung-Hye You, et al.
Journal of Neuro-Oncology|September 11, 2014
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imagingSeunghyun Lee, Seung Hong Choi, Inseon Ryoo, et al.
Oncoimmunology|January 17, 2022
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade gliomaA-Reum Kim, Seong Jin Choi, Junsik Park, et al.
International Journal of Computer Assisted Radiology and Surgery|July 13, 2023
Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigationYun-Sik Dho, Byeong Cheol Lee, Hyeong Cheol Moon, et al.
Plos One|November 25, 2014
Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagingJae Hyun Kim, Seung Hong Choi, Inseon Ryoo, et al.
Acta Neuropathologica Communications|June 5, 2019
Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastomaTaeyoung Hwang, Dimitrios Mathios, Kerrie L McDonald, et al.
European Radiology|July 1, 2016
Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imagingRihyeon Kim, Seung Hong Choi, Tae Jin Yun, et al.
Acta Neuropathologica Communications|July 16, 2024
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitorsEric Eunshik Kim, Chul-Kee Park, Seung-Ki Kim, et al.
Neurosurgery|December 5, 2012
Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single instituteJin Wook Kim, Dong Gyu Kim, In Kyeong Kim, et al.
Plos One|November 12, 2016
MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis PredictionBo Ram Kim, Seung Hong Choi, Tae Jin Yun, et al.
Pageof 34

Showing results (211-220 of 334) with videos related to

Sort By:
Pageof 34
Plos One|November 19, 2016
Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR ImagingLeonard Sunwoo, Tae Jin Yun, Sung-Hye You, et al.
Journal of Neuro-Oncology|September 11, 2014
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imagingSeunghyun Lee, Seung Hong Choi, Inseon Ryoo, et al.
Oncoimmunology|January 17, 2022
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade gliomaA-Reum Kim, Seong Jin Choi, Junsik Park, et al.
International Journal of Computer Assisted Radiology and Surgery|July 13, 2023
Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigationYun-Sik Dho, Byeong Cheol Lee, Hyeong Cheol Moon, et al.
Plos One|November 25, 2014
Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagingJae Hyun Kim, Seung Hong Choi, Inseon Ryoo, et al.
Acta Neuropathologica Communications|June 5, 2019
Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastomaTaeyoung Hwang, Dimitrios Mathios, Kerrie L McDonald, et al.
European Radiology|July 1, 2016
Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imagingRihyeon Kim, Seung Hong Choi, Tae Jin Yun, et al.
Acta Neuropathologica Communications|July 16, 2024
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitorsEric Eunshik Kim, Chul-Kee Park, Seung-Ki Kim, et al.
Neurosurgery|December 5, 2012
Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single instituteJin Wook Kim, Dong Gyu Kim, In Kyeong Kim, et al.
Plos One|November 12, 2016
MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis PredictionBo Ram Kim, Seung Hong Choi, Tae Jin Yun, et al.
Pageof 34